Intron Biotechnology, Inc.

Soon Hye Hwang

SAng Hyeon Kang

Seong Jun Yoon

Soo Youn Jun

An Sung Kwon

Hyun Min Song

Jung In Pyo

Ji In Jung

The present invention relates tobacteriophage Vib-PAP-4(Accession No. KCTC 13168BP), isolated from nature, which possesses ability to specifically killbacteria and has the genome represented by SEQ ID No: 1, and a method for preventing infection ofbacteria and treating infection ofbaceteria, using a composition containing the bacteriophage as an effective ingredient.

bacteriophage Vib-PAP-4 and use thereof in inhibiting proliferation ofbacteria

The present invention relates tobacteriophage Vib-ANP-1(accession number KCTC 13075BP) having the ability to specifically killbacteria and a genome represented by SEQ ID NO: 1 and isolated from nature, and a method for prevention or treatment ofbacterial infection by using a composition containing the same bacteriophage as an effective ingredient.

[object Object]

The present invention relates to Siphoviridae bacteriophage Lac-GAP-3 (Accession Number KCTC 12816BP) having the ability to specifically killbacteria and a genome represented by SEQ ID NO: 1 and isolated from nature, and a method for prevention and treatment ofbacterial infection by using a composition containing the same bacteriophage as an effective ingredient.

bacteriophage Lac-GAP-3 and use thereof in inhibiting proliferation ofbacteria

The present invention relates to: Podoviridae bacteriophage Vib-PAP-2 (accession number KCTC 12910BP) which has the capability to specifically destroy, is characterized by having a genome represented by SEQ ID NO: 1, and is isolated from nature; and a method for preventing and treatinginfections, using a composition containing bacteriophage Vib-PAP-2 as an active ingredient.

Vibrio parahaemolyticus bacteriophage Vib-PAP-2 and use thereof for inhibiting proliferation of

Described is heme iron having Chemical Formula 1 not derived from porcine blood and a method of preparing the same, and more particularly to a method of chemically preparing heme iron having Chemical Formula 1 not derived from porcine blood, a method of preparing a salt thereof, and an iron supplement containing the salt thus prepared as an active ingredient: 

Chemical method for preparing heme iron not derived from porcine blood

The present invention relates to: Podoviridae bacteriophage Vib-PAP-1 (accession number KCTC 12817BP) which has the capability to specifically destroy, is characterized by having a genome represented by SEQ ID NO: 1, and is isolated from nature; and a method for preventing and treatinginfections, using a composition containing bacteriophage Vib-PAP-1 as an active ingredient.

Vibrio parahaemolyticus bacteriophage Vib-PAP-1 and use thereof for inhibiting proliferation of vibrio parahaemolyticus

The present invention relates to heme iron not derived from porcine blood and a method of preparing the same, and more particularly to a method of biologically preparing heme iron not derived from porcine blood, a method of preparing a salt thereof, and an iron supplement containing the salt thus prepared as an active ingredient.

Biological method for preparing heme iron not derived from porcine blood

The present invention relates to a Myoviridae bacteriophage Lac-GAP-1 that is isolated from the nature and can kill specificallycells, which has a genome represented by the nucleotide sequence of SEQ ID NO: 1 (Accession NO: KCTC 12686BP), and a method for preventing and treating the infections ofusing the composition comprising said bacteriophage as an active ingredient.

Growing community of inventors

Gyeonggi-do, South Korea

Soon Hye Hwang